AbbVie Inc. (BMV:ABBV)
Mexico flag Mexico · Delayed Price · Currency is MXN
3,877.00
-23.00 (-0.59%)
Last updated: Feb 10, 2026, 10:42 AM CST

AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of MXN 6.78 trillion. The enterprise value is 7.87 trillion.

Market Cap6.78T
Enterprise Value 7.87T

Important Dates

The last earnings date was Wednesday, February 4, 2026.

Earnings Date Feb 4, 2026
Ex-Dividend Date Jan 16, 2026

Share Statistics

Current Share Class 1.77B
Shares Outstanding n/a
Shares Change (YoY) n/a
Shares Change (QoQ) +0.11%
Owned by Insiders (%) 0.06%
Owned by Institutions (%) 73.80%
Float 1.76B

Valuation Ratios

The trailing PE ratio is 89.12 and the forward PE ratio is 15.23.

PE Ratio 89.12
Forward PE 15.23
PS Ratio 6.16
PB Ratio -144.92
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 103.40
EV / Sales 7.49
EV / EBITDA 15.56
EV / EBIT 21.58
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA 2.34
Debt / FCF n/a
Interest Coverage 8.08

Financial Efficiency

Return on equity (ROE) is 1,106.67% and return on invested capital (ROIC) is 22.47%.

Return on Equity (ROE) 1,106.67%
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 22.47%
Return on Capital Employed (ROCE) n/a
Weighted Average Cost of Capital (WACC) 5.60%
Revenue Per Employee 20.02M
Profits Per Employee 1.38M
Employee Count55,000
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, AbbVie has paid 42.56 billion in taxes.

Income Tax 42.56B
Effective Tax Rate 35.83%

Stock Price Statistics

The stock price has decreased by -1.14% in the last 52 weeks. The beta is 0.35, so AbbVie's price volatility has been lower than the market average.

Beta (5Y) 0.35
52-Week Price Change -1.14%
50-Day Moving Average 4,075.80
200-Day Moving Average 3,851.28
Relative Strength Index (RSI) 47.18
Average Volume (20 Days) 1,156

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 3.42

Income Statement

In the last 12 months, AbbVie had revenue of MXN 1.10 trillion and earned 76.08 billion in profits. Earnings per share was 42.49.

Revenue1.10T
Gross Profit 788.86B
Operating Income 381.92B
Pretax Income 118.77B
Net Income 76.08B
EBITDA 529.59B
EBIT 381.92B
Earnings Per Share (EPS) 42.49
Full Income Statement

Balance Sheet

The company has 102.10 billion in cash and 1.24 trillion in debt, with a net cash position of -1,137.41 billion.

Cash & Cash Equivalents 102.10B
Total Debt 1.24T
Net Cash -1,137.41B
Net Cash Per Share n/a
Equity (Book Value) -46.79B
Book Value Per Share -26.91
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 71.64%, with operating and profit margins of 34.69% and 6.91%.

Gross Margin 71.64%
Operating Margin 34.69%
Pretax Margin 10.79%
Profit Margin 6.91%
EBITDA Margin 48.10%
EBIT Margin 34.69%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 124.74, which amounts to a dividend yield of 3.20%.

Dividend Per Share 124.74
Dividend Yield 3.20%
Dividend Growth (YoY) 7.00%
Years of Dividend Growth 2
Payout Ratio n/a
Buyback Yield -0.23%
Shareholder Yield 2.97%
Earnings Yield 1.12%
FCF Yield n/a
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2